Evidence map›Paper›PMID 26887580›Full record

ArticleNeurosurgical review2016

Laser biospectroscopy and 5-ALA fluorescence navigation as a helpful tool in the meningioma resection.

A A Potapov, S A Goryaynov, V A Okhlopkov, L V Shishkina, V B Loschenov, T A Savelieva, D A Golbin, A P Chumakova, M F Goldberg, M D Varyukhina and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

A A PotapovBurdenko Neurosurgical Institute, Moscow, Russia.
S A GoryaynovBurdenko Neurosurgical Institute, Moscow, Russia.
V A OkhlopkovBurdenko Neurosurgical Institute, Moscow, Russia.
L V ShishkinaBurdenko Neurosurgical Institute, Moscow, Russia.
V B LoschenovA. M. Prokhorov General Physics Institute, Moscow, Russia.
T A SavelievaA. M. Prokhorov General Physics Institute, Moscow, Russia.
D A GolbinBurdenko Neurosurgical Institute, Moscow, Russia.
A P ChumakovaFaculty of Basic Medicine, Lomonosov Moscow State University, Moscow, Russia.
M F GoldbergI.M. Sechenov First Moscow State Medical University, Moscow, Russia.
M D VaryukhinaThe Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia.
A SpalloneDepartment of Biomedicine, University or Rome "Tor Vergata" and NCL-Institute of Neurological Sciences, Rome, Italy. segreteria1@nclroma.it.
Burdenko Neurosurgery Institute · RUProkhorov General Physics Institute · RULomonosov Moscow State University · RUSechenov University · RUUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-aminolevulinic acid (5-ALA) is a natural precursor of protoporphyrin IX (PP IX), which possesses fluorescent properties and is more intensively accumulated in tumor cells than in normal tissue. Therefore, the use of 5-ALA in the surgical treatment of intracranial tumors, particularly gliomas, has gained popularity in the last years, whereas its use in other intracranial pathological entities including meningiomas has been reported occasionally. This study describes a series of 28 patients with intracranial meningiomas, who were administered 5-ALA for a better visualization of tumor boundaries. Twelve patients underwent also laser spectroscopic analysis in order to confirm the visual impression of tumor tissue visualization. Bone infiltration was readily demonstrated. In one case, the tumor recurrence could have been prevented by removal of a tumor remnant, which would possibly have been better recognized if spectroscopic analysis had been used. Fluorescent navigation (FN) is a useful method for maximizing the radicality of meningioma surgery, particularly if the tumor infiltrates the bone, the skull base, and/or the surrounding structures.

Indexed as

AdultAgedAminolevulinic AcidFemaleFluorescenceHumansMaleMeningeal NeoplasmsMeningiomaMiddle AgedNeoplasm Recurrence, LocalNeurosurgical ProceduresAminolevulinic Acid5-ALAFluorescent navigationIntracranial meningiomaLaser spectroscopic analysisSurgical treatment

Identifiers

PMID26887580
OpenAlexW2283855893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.